Theriva Biologics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-12.9M | $-12.9M | $14.0K | $416.0K |
| FY2022 | $-19.1M | $-19.2M | $116.0K | $475.0K |
| FY2023 | $-19.0M | $-19.2M | $202.0K | $552.0K |
| FY2024 | $-16.9M | $-16.9M | $1.0K | $671.0K |
| FY2025 | $-16.7M | $-16.7M | $35.0K | $654.0K |